We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+31.23%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$550M
AUM Growth
+$70.6M
Cap. Flow
-$37M
Cap. Flow %
-6.73%
Top 10 Hldgs %
19.32%
Holding
327
New
24
Increased
23
Reduced
152
Closed
29

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.02M
2
GEV icon
GE Vernova
GEV
+$2.92M
3
COHU icon
Cohu
COHU
+$2.47M
4
MAMA icon
Mama's Creations
MAMA
+$2.39M
5
ORN icon
Orion Group Holdings
ORN
+$2.25M

Top Sells

Rank Stock Value
1
NUTX
Nutex Health
NUTX
+$7.08M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.56M
3
TVTX icon
Travere Therapeutics
TVTX
+$4.56M
4
GNRC icon
Generac Holdings
GNRC
+$3.88M
5
GWRE icon
Guidewire Software
GWRE
+$3.34M

Sector Composition

Rank Sector Weight
1 Industrials 30.33%
2 Technology 26.01%
3 Healthcare 18.4%
4 Financials 6.04%
5 Consumer Staples 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KGC icon
251
Kinross Gold
KGC
$31.9B
$41.6K 0.01%
2,661
– –
V icon
252
Visa
V
$676B
$41.5K 0.01%
117
– –
UPS icon
253
United Parcel Service
UPS
$89.3B
$40.8K 0.01%
404
– –
DTM icon
254
DT Midstream
DTM
$13.9B
$40K 0.01%
364
– –
EPD icon
255
Enterprise Products Partners
EPD
$82B
$39.3K 0.01%
1,266
– –
AYI icon
256
Acuity Brands
AYI
$10.8B
$39.1K 0.01%
131
– –
BRK.B icon
257
Berkshire Hathaway Class B
BRK.B
$1.09T
$36.9K 0.01%
76
– –
FLS icon
258
Flowserve
FLS
$10.2B
$36.5K 0.01%
697
+98
+16% +$4.61K
ALKT icon
259
Alkami Technology
ALKT
$2.19B
$36.3K 0.01%
1,204
+290
+32% +$8.06K
G icon
260
Genpact
G
$5.77B
$36.2K 0.01%
823
– –
TT icon
261
Trane Technologies
TT
$105B
$35.4K 0.01%
81
-69
-46% -$27.2K
AXTA icon
262
Axalta
AXTA
$7.97B
$33.3K 0.01%
1,123
– –
RIO icon
263
Rio Tinto
RIO
$161B
$33.1K 0.01%
567
-450
-44% -$26.6K
VERX icon
264
Vertex
VERX
$2.04B
$32.8K 0.01%
929
– –
ETN icon
265
Eaton
ETN
$177B
$31.4K 0.01%
88
– –
SRE icon
266
Sempra
SRE
$56.6B
$29.6K 0.01%
390
– –
ACA icon
267
Arcosa
ACA
$7.14B
$28.7K 0.01%
331
– –
DAN icon
268
Dana Inc
DAN
$3.19B
$28.6K 0.01%
1,665
– –
MA icon
269
Mastercard
MA
$493B
$28.1K 0.01%
50
– –
DXCM icon
270
DexCom
DXCM
$34.4B
$27.8K 0.01%
318
– –
IFX
271
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
$25.8K ﹤0.01%
607
– –
CWAN
272
DELISTED
Clearwater Analytics
CWAN
$25.6K ﹤0.01%
1,166
– –
SLV icon
273
iShares Silver Trust
SLV
$31.5B
$25.3K ﹤0.01%
771
– –
ROK icon
274
Rockwell Automation
ROK
$49.8B
$23.3K ﹤0.01%
70
– –
ECL icon
275
Ecolab
ECL
$78B
$22.4K ﹤0.01%
83
– –
9 10
11
12 13

Similar funds

BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return
FTC
Farmers Trust Company Youngstown, Ohio $637M AUM 23.14% 1-Year Est. Return

Essex Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Essex Investment Management held 327 positions worth $550M, up 15% from $479M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Essex Investment Management withdrew a net $37M in Q2 2025, closing 29 positions and reducing 152 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Mirum Pharmaceuticals worth $5.74M.

  • Essex Investment Management's largest Q2 2025 buy was Mirum Pharmaceuticals: 112,731 shares worth $5.74M.
  • Essex Investment Management added most to GE Vernova in Q2 2025, an estimated $2.92M increase.
  • Essex Investment Management's biggest Q2 2025 reduction was Nutex Health, cutting an estimated $7.08M.
  • Essex Investment Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $6.56M.
  • Essex Investment Management's ten largest holdings make up 19% of its $550M portfolio in Q2 2025.
  • Essex Investment Management opened 24 new positions and closed 29 in Q2 2025.
  • Essex Investment Management's portfolio value rose 15% quarter-over-quarter to $550M.

Based on Essex Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.